Other Information
+Added: September 2021, Ellen Lintal informed us that she intended to retire as Chief Financial Officer effective March 31, 2022 and, therefore,
+Added: would not be renewing her contract.
+Added: The retirement date permits her to prepare and file our next annual report on Form 10-K for the year
+Added: ending December 31, 2021.
+Added: Lintal has agreed to remain available to us after her retirement — on a contractual basis —
+Added: to assist with future annual and quarterly filings with the SEC.
July 8, 2021 Reservation and Start-Up Agreement with hVIVO Services Limited (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))*
−Removed: May 21, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited.*
−Removed: April 19, 2021 Purchase and Sale Agreement with Phoenix Equipment Corporation, Branford Auctions, LLC and Perry Videx LLC.**
−Removed: Material Transfer and Research agreement with Roswell Park Comprehensive Cancer Center executed on April 14, 2021 (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10)).**
−Removed: 1, 2021 extension of April 1, 2020 Material Transfer and Research Agreement with Shenzhen Smoore Technology Limited.**
−Removed: Material Transfer And Research Agreement with the University of Cagliari Dipartimento di Scienze della Vita e dell’Ambiente executed on April 5, 2021 (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10)).**
−Removed: May 12, 2021 Amendment to the Renewed Sales, Marketing, Distribution and Supply Agreement with GPPharm.
−Removed: (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))**
+Added: September 27, 2021 Clinical Trial Agreement with hVIVO Services Limited (Portions of this Agreement have been redacted in compliance with Regulation S-K Item 601(b)(10))**
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 from the Company’s Chief Executive Officer.* *
8 unchanged sentences
Taxonomy Extension Presentation Linkbase Document ** ***
−Removed: Filed herewith.
+Added: Cover Page Interactive Data File (embedded within the Inline XBRL document)
Filed with the Securities and Exchange Commission as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended
−Removed: March 31, 2021 filed May 17, 2021 and is hereby incorporated by reference.
+Added: June 30, 2021 filed August 16, 2021 and is hereby incorporated by reference.
+Added: Filed herewith.
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus
6 unchanged sentences
Financial Officer
−Removed: August 16, 2021
+Added: November 15, 2021
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.